Cargando…

Advanced Hodgkin Lymphoma: a New Era of Therapy

Therapy of advanced Hodgkin lymphoma (HL) is a rapidly changing field due to a lot of currently emerging data. Treatment approaches are presently based on either the Kairos principle of giving aggressive therapy upfront and considering de-escalation of therapy if the interim PET/CT is negative or th...

Descripción completa

Detalles Bibliográficos
Autor principal:	Dann, Eldad J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165498/ https://www.ncbi.nlm.nih.gov/pubmed/25237476 http://dx.doi.org/10.4084/MJHID.2014.063

Ejemplares similares

Hodgkin Disease—An Ever-Evolving Therapy
por: Dann, Eldad J.
Publicado: (2014)

Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies
por: Mohty, Razan, et al.
Publicado: (2021)

Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel Therapies
por: Paviglianiti, Annalisa, et al.
Publicado: (2023)

Autologous Stem Cell Transplantation in Hodgkin Lymphoma—Latest Advances in the Era of Novel Therapies
por: Samara, Yazeed, et al.
Publicado: (2022)

HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART
por: Jacobson, Caron A., et al.
Publicado: (2012)

Radiation Therapy for Advanced-Stage Hodgkin Lymphoma
por: Lockney, Natalie A., et al.
Publicado: (2020)

Classical Hodgkin’s Lymphoma in the Era of Immune Checkpoint Inhibition
por: De Re, Valli, et al.
Publicado: (2019)

AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy
por: Vishnu, Prakash, et al.
Publicado: (2012)

Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin’s Lymphoma
por: Alfaifi, Abdullah, et al.
Publicado: (2023)

Yescarta: A New Era for Non-Hodgkin Lymphoma Patients
por: AlDallal, Salma M
Publicado: (2020)

Reduction of the Vertebral Bone Mineral Density in Patients with Hodgkin Lymphoma Correlates with Their Age and the Treatment Regimen They Received
por: Ofshenko, Nadav, et al.
Publicado: (2022)

PET-adapted approaches to primary therapy for advanced Hodgkin lymphoma
por: Lang, Noemie, et al.
Publicado: (2020)

Recent advances in the management of Hodgkin lymphoma
por: Villasboas, Jose C., et al.
Publicado: (2016)

The Legacy of Thomas Hodgkin Is Still Relevant 150 Years After His Death. Nothing of Humanity Was Foreign to Him
por: Dann, Eldad J.
Publicado: (2017)

BENDAMUSTINE: AN OLD DRUG IN THE NEW ERA FOR PATIENTS WITH NON-HODGKIN LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA
por: Bogeljić Patekar, Martina, et al.
Publicado: (2018)

Minimising the Toxicities of First Line Hodgkin Lymphoma Treatment in the Modern Era
por: Follows, Annabel M., et al.
Publicado: (2022)

Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy
por: Randall, Michael P., et al.
Publicado: (2023)

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
por: Grover, Natalie S., et al.
Publicado: (2015)

A Review of Hodgkin Lymphoma in the Era of Checkpoint Inhibitors
por: Schimmoeller, Christopher J, et al.
Publicado: (2023)

Patients with Hodgkin Lymphoma Develop Adequate Humoral Serological Response to Vaccination with Two Doses of BNT162b2
por: Dann, Eldad J, et al.
Publicado: (2021)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma
por: Wang, Yucai, et al.
Publicado: (2018)

Adoptive T-cell therapy for Hodgkin lymphoma
por: Ho, Carrie, et al.
Publicado: (2021)

Current advances in Hodgkin’s lymphoma
por: Vadakara, Joseph, et al.
Publicado: (2019)

Genetic lesions and targeted therapy in Hodgkin lymphoma
por: Li, Zhe, et al.
Publicado: (2023)

Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
por: Yin, Zixun, et al.
Publicado: (2021)

Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era
por: Lapuz, Carminia, et al.
Publicado: (2018)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
por: Katsin, Mikalai, et al.
Publicado: (2023)

Advances in the treatment of Hodgkin's lymphoma (Review)
por: Che, Yuxuan, et al.
Publicado: (2023)

Fertility preservation in Hodgkin’s lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era
por: Traila, Alexandra, et al.
Publicado: (2018)

Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances
por: Derenzini, Enrico, et al.
Publicado: (2011)

Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma
por: Vellemans, Hélène, et al.
Publicado: (2021)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

Hypotension Associated with Advanced Hodgkin Lymphoma
por: Mangla, Ankit, et al.
Publicado: (2014)

Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies
por: Karantanos, Theodoros, et al.
Publicado: (2017)

Managing advanced stage Hodgkin lymphoma
por: Saikia, TK
Publicado: (2015)

Editorial: Advances in the treatment of Hodgkin lymphoma
por: Mei, Matthew, et al.
Publicado: (2023)

CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi
por: Gopal, Satish, et al.
Publicado: (2016)

Pathobiology of Hodgkin Lymphoma
por: Agostinelli, Claudio, et al.
Publicado: (2014)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jhi9chpn72neu5tme4t31l2us0